Aerovate Therapeutics, Inc. - COM (AVTE)

Historical Portfolio Holders from Q2 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
27.6M
Holdings value Q3 2024
$57.8M
Value change Q3 2024
+$1.54M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
72
Number of buys Q3 2024
33
Number of sells Q3 2024
-37
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 27.6M $57.8M +$1.54M $2.09 74
2024 Q2 27.2M $45.1M -$189M $1.66 83
2024 Q1 28.4M $841M +$12.9M $29.57 79
2023 Q4 24.4M $552M -$448K $22.63 62
2023 Q3 28.5M $386M -$1.3M $13.57 58
2023 Q2 28.5M $488M +$39.1M $17.15 60
2023 Q1 26M $524M -$46.6M $20.17 65
2022 Q4 27.4M $803M +$17.8M $29.30 68
2022 Q3 27M $447M +$20.2M $16.58 53
2022 Q2 25.8M $403M -$2.77M $15.63 47
2022 Q1 25.9M $475M +$8.65M $18.33 44
2021 Q4 25.6M $301M -$15.3M $11.79 46
2021 Q3 21.7M $453M +$35.1M $20.98 41
2021 Q2 20M $454M +$454M $22.83 17